|
|
Volumn 22, Issue 5, 2008, Pages 671-677
|
|
The introduction of verteporfin photodynamic therapy in the UK: PDT users group (PDTUG) surveillance programme report 1
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
VERTEPORFIN;
AGED;
ARTICLE;
BACKACHE;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
EYE IRRITATION;
EYE TOXICITY;
FOLLOW UP;
HEALTH SURVEY;
HUMAN;
INJECTION SITE EXTRAVASATION;
INJECTION SITE PAIN;
INTRAOCULAR HEMORRHAGE;
MAJOR CLINICAL STUDY;
MEDICAL RECORD;
MULTICENTER STUDY;
NEUROTOXICITY;
OUTCOME ASSESSMENT;
PHOTODYNAMIC THERAPY;
PHOTOSENSITIVITY;
RETINA MACULA AGE RELATED DEGENERATION;
RETINA TEAR;
SUBRETINAL NEOVASCULARIZATION;
THORAX PAIN;
TREATMENT DURATION;
UNITED KINGDOM;
VISUAL ACUITY;
VISUAL IMPAIRMENT;
VISUAL SYSTEM EXAMINATION;
|
|
EID: 44049087858
PISSN: 0950222X
EISSN: 14765454
Source Type: Journal
DOI: 10.1038/sj.eye.6702713 Document Type: Article |
|
Times cited : (2)
|
|
References (16)
|
